Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Clears Validation Testing For Automated Endoscope Reprocessors

This article was originally published in The Gray Sheet

Executive Summary

FDA has found that validation test data for three automated endoscope reprocessors – including Medivators’ Advantage Plus and DSD Edge, and Steris’ System 1E Liquid Chemical Sterilant Processing System are adequate.


Related Content

Facilities Must Stop Using Custom Ultrasonics' System To Reprocess Duodenoscopes, FDA Warns
FDA Lays Down Strict Disinfection Guidance In Wake Of Scope Incidents


Related Companies